Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds antigen or epitope whose amino acid sequence is...
Patent
1995-06-07
1999-09-21
Saunders, David
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds antigen or epitope whose amino acid sequence is...
4241451, 4241851, 4241931, 4242781, 530327, 530328, 530350, 5303871, 53038822, 5303881, 5303891, 530403, 530806, 530807, 530810, A61K 39395, A61K 3935, A61K 39385, A61K 3804
Patent
active
059550767
ABSTRACT:
An immunogen comprising a residue of a histamine-releasing peptide comprising a cationic N-terminal head and a hydrophobic C-terminal tail, together with a residue capable of eliciting antibodies against said peptide whilst inhibiting histamine release by said peptide is useful in anti-allergy treatment. Preferably the histamine-releasing peptide is of formula:
REFERENCES:
patent: 4161522 (1979-07-01), Hamburger et al.
patent: 4223016 (1980-09-01), Roy et al.
patent: 4579840 (1986-04-01), Hahn
patent: 4683292 (1987-07-01), Hahn
patent: 5283243 (1994-02-01), Jasserand et al.
patent: 5601821 (1997-02-01), Stanworth et al.
Jones Valerie
Lewin Ian Victor
Nayyar Sarita
Stanworth Denis Raymond
Peptide Therapeutics Limited
Saunders David
VanderVegt F. Pierre
LandOfFree
Immunoactive peptides and antibodies and their use in anti-aller does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoactive peptides and antibodies and their use in anti-aller, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoactive peptides and antibodies and their use in anti-aller will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-77571